glucose-dependent insulinotropic polypeptide (GIP)
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for glucose-dependent insulinotropic polypeptide (GIP), covering 2008-10-17 to 2026-01-09. Get the full timeline:
Most recent: Clinical Trial Update: The Separate and Combined Glucagonotropic Effects of Glucose-dependent Insulinotropic Polypeptide and Alanine in Subjects With and Without Type 1 Diabetes [NA]